Previous close | 123.99 |
Open | 127.08 |
Bid | 117.65 x 200 |
Ask | 117.97 x 100 |
Day's range | 117.67 - 127.75 |
52-week range | 89.00 - 213.91 |
Volume | |
Avg. volume | 1,621,741 |
Market cap | 18.781B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference:
Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today announced its financial results for the first quarter of fiscal year 2024, which include the consolidated financial results for GRAIL.
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced it has received approval of its divestment plan for GRAIL from the European Commission (EC).